Medical Digest & Congress Report

Targeting CD19+ B-Cells in IgG4-Related Disease: Clinical Evidence and Implications for Long-Term Management - Report from EULAR 2026 Jun 15, 2026 00:15:18 Dr. Emanuel Della Torre discusses the clinical evidence behind targeting CD19+ B-cells in IgG4-related disease in a post-congress interview following EULAR 2026. This recap focuses on the therapeutic impact of these strategies, underlying immunological mechanisms, and the long-term management implications for patients in clinical practice.Video: https://medicaldigest.org/scientific-contents/interv

State-of-the-Art Treatment in Psoriatic Arthritis - Report from EULAR 2026 Jun 15, 2026 00:23:50 Professor Laura C. Coates highlights the rapidly evolving landscape of state-of-the-art treatments for psoriatic arthritis (PsA) in a post-congress interview following EULAR 2026. This recap focuses on personalized management pathways, novel targeted therapies, and strategic frameworks aimed at optimizing long-term patient outcomes.Video: https://medicaldigest.org/scientific-contents/interview:sta

The RA Paradigm Shift: New Insights into Pathogenesis and a Pipeline of Promise - Report from EULAR 2026 Jun 15, 2026 00:05:46 Professor Elena Nikiphorou discusses the ongoing paradigm shift in rheumatoid arthritis (RA), presented at the EULAR 2026 Congress. This recap focuses on novel insights into RA pathogenesis and explores the promising therapeutic pipeline, highlighting how these scientific advancements are translating into more targeted, effective management strategies for clinical practice.Video: https://medicaldi

Systemic Sclerosis: Deciphering Pathogenesis, Unveiling Comorbidities, and Paving the Way for Targeted Treatment - Report from EULAR 2026 Jun 15, 2026 00:10:47 Professor Oliver Distler dives into the complex landscape of systemic sclerosis (SSc), presented at the EULAR 2026 Congress. This recap focuses on recent breakthroughs in deciphering SSc pathogenesis, identifying and managing critical comorbidities, and evaluating emerging therapeutic strategies that pave the way for highly targeted clinical treatments.Video: https://medicaldigest.org/scientific-c

EULAR / ACR Classification Criteria for Anti-Synthetase Syndrome - Report from EULAR 2026 Jun 15, 2026 00:06:07 Professor Lorenzo Cavagna discusses the developed EULAR / ACR classification criteria for anti-synthetase syndrome, presented at the EULAR 2026 Congress. This recap highlights the critical diagnostic parameters, clinical features, and serological markers involved in these standardized criteria, aiming to improve early recognition and harmonize research and patient care globally.Video: https://medi

Workflow in Focus: Advancing Global Health in Rheumatology - Report from EULAR 2026 Jun 15, 2026 00:04:09 Professor Annelies Boonen explores systemic workflows and their critical role in advancing global healthcare within rheumatology, presented at the EULAR 2026 Congress. This recap highlights optimized clinical pathways, health economics, and strategic workflow improvements designed to enhance patient care and sustainability on a global scale.Video: https://medicaldigest.org/scientific-contents/inte

Diagnosing Osteoporosis in Inflammatory Rheumatic Conditions - Report from EULAR 2026 Jun 15, 2026 00:06:29 Professor Radmila Matijevic addresses the complexities of diagnosing osteoporosis within the context of inflammatory rheumatic conditions, presented at the EULAR 2026 Congress. This recap focuses on best practices for early identification, the impact of chronic inflammation on bone density, and diagnostic strategies to effectively assess fracture risk in this specific patient population.Video: htt

Biosimilars in Focus: Advancing Global Health in Rheumatology - Report from EULAR 2026 Jun 15, 2026 00:06:58 Professor Tore K. Kvien explores the evolving landscape of biosimilars and their vital role in advancing global healthcare within rheumatology, presented at the EULAR 2026 Congress. This recap highlights clinical application, access strategies, and the overall impact of biosimilar therapies in improving patient outcomes and healthcare sustainability on a global scale.Video: https://medicaldigest.o

Treating Hypertension in the Elderly: Insights from the ESH Congress Jun 15, 2026 00:08:23 Dr. Paul Whelton shares critical insights from the ESH Congress on the management of hypertension in the elderly. While high blood pressure is highly prevalent in older age and carries an elevated cardiovascular risk, clinical practice often overestimates the risks of treatment. This expert overview challenges common misconceptions, highlighting how the elderly are frequently undertreated and emph

Screen, Monitor and Manage CTD-ILD: Practical Application of ERS/EULAR Guidelines and Expert Insights - Report from EULAR 2026 Jun 15, 2026 00:06:57 Dr. Francesco Del Galdo discusses the screening, monitoring, and management of connective tissue disease-associated interstitial lung disease (CTD-ILD), presented at the EULAR 2026 Congress. This recap focuses on the practical application of the joint ERS/EULAR guidelines, highlighting key diagnostic steps, monitoring tools, and therapeutic strategies to handle lung involvement in clinical practic

Treatment of Rheumatoid Arthritis Associated Interstitial Lung Disease - Report from EULAR 2026 Jun 15, 2026 00:03:41 Dr. Philippe Dieudé discusses current strategies for treating interstitial lung disease associated with rheumatoid arthritis (RA-ILD), presented at the EULAR 2026 Congress. This recap focuses on the management of pulmonary complications, the selection of appropriate immunosuppressive or antifibrotic therapies, and the clinical approach needed to stabilize lung function in these patients.Video: htt

Promote Happiness: Rethinking Care for Brighter Outcomes in Older Adults with RMDs - Report from EULAR 2026 Jun 15, 2026 00:10:36 Dr. José Antonio P. Da Silva discusses the importance of promoting happiness and well-being in older adults living with rheumatic and musculoskeletal diseases (RMDs), presented at the EULAR 2026 Congress. This recap focuses on rethinking traditional care models by incorporating psychological health and positive outcomes alongside standard medical management to improve the overall quality of life f

Improving Care in Spondyloarthritis: A Multidisciplinary Approach to the Disease and Its Extra-Musculoskeletal Manifestations - Report from EULAR 2026 Jun 15, 2026 00:04:42 Dr. Filip Van den Bosch discusses strategies for improving care in spondyloarthritis, presented at the EULAR 2026 Congress. This recap focuses on the practical use of a multidisciplinary approach to manage both joint symptoms and extra-musculoskeletal manifestations, such as uveitis, psoriasis, and inflammatory bowel disease, to achieve better overall patient outcomes.Video: https://medicaldigest.

HPR Sessions at EULAR 2026 Jun 15, 2026 00:03:28 Dr. Mwidimi Ndosi provides an overview of the key Health Professionals in Rheumatology (HPR) sessions at the EULAR 2026 Congress. This recap highlights the main topics discussed, including collaborative care models, the expanding role of non-physician specialists, and practical strategies implemented to enhance multidisciplinary teamwork in daily clinical practice.Video: https://medicaldigest.org/

The Patient is in the Middle - Report from EULAR 2026 Jun 15, 2026 00:04:42 Dr. Mwidimi Ndosi explains the role of patient-centered care in rheumatology, presented at the EULAR 2026 Congress. This recap covers the practical use of shared decision-making and how involving the patient in the care team helps improve treatment adherence and clinical outcomes.Video: https://medicaldigest.org/scientific-contents/interview:patient-middle

Secukinumab in Polymyalgia Rheumatica: Results of the Phase 3 REPLENISH Trial - Report from EULAR 2026 Jun 15, 2026 00:04:16 Dr. Christian Dejaco presents highly anticipated data from the Phase 3 REPLENISH trial, evaluating the efficacy and safety of secukinumab in patients with Polymyalgia Rheumatica (PMR), highlighted at the EULAR 2026 Congress. This breakthrough recap examines how targeting the IL-17A pathway provides a powerful steroid-sparing therapeutic alternative, significantly improving clinical remission rates

No Pain is THE Gain in Rheumatoid Diseases - Report from EULAR 2026 Jun 15, 2026 00:10:29 Dr. Lars Arendt-Nielsen delivers a compelling expert perspective on revolutionizing treatment priorities in rheumatic and musculoskeletal diseases, featured at the EULAR 2026 Congress. This brief explores the complex mechanisms of chronic pain, moving beyond traditional inflammatory markers to emphasize that achieving true, long-term pain remission is the ultimate measure of therapeutic success an

Unveiling Novel Antibodies and Their Practical Implication in RMDs - Report from EULAR 2026 Jun 15, 2026 00:07:23 Dr. Diane van der Woude provides a fascinating expert overview of the discovery of novel autoantibodies and their clinical translation in rheumatic and musculoskeletal diseases (RMDs), presented at the EULAR 2026 Congress. This recap highlights the latest breakthroughs in biomarker identification, how these emerging antibody profiles refine early diagnosis and risk stratification, and their practi

HPR: Patient Education, Support and Improving Access to Rheumatology Care - Report from EULAR 2026 Jun 15, 2026 00:03:55 Rikke Helene Moe, EULAR Vice-President HPR, delivers an inspiring expert overview of the vital role Health Professionals in Rheumatology (HPR) play in transforming patient care, highlighted at the EULAR 2026 Congress. This brief focuses on the latest advancements in structured patient education, comprehensive support frameworks, and innovative multi-disciplinary strategies aimed at breaking down b

Pain Management in Rheumatological Diseases - Report from EULAR 2026 Jun 15, 2026 00:05:23 Dr. Jasminka Milas-Ahic provides a comprehensive expert overview of the contemporary challenges and advancements in pain management across rheumatological diseases, presented at the EULAR 2026 Congress. This recap explores the critical shift toward multimodal treatment strategies, the integration of pharmacological and non-pharmacological interventions, and how addressing centralized pain mechanis

Managing Comorbidities in Systemic Sclerosis to Achieve Better Outcome - Report from EULAR 2026 Jun 15, 2026 00:07:59 Dr. Claudia Iannone delivers a vital expert perspective on the strategic management of comorbidities in patients with Systemic Sclerosis, featured at the EULAR 2026 Congress. This brief emphasizes the profound impact of overlapping systemic, cardiovascular, and metabolic complications on disease progression, highlighting the integrated care approaches and proactive screening protocols essential fo

Managing Comorbidities in Rheumatoid Arthritis for Better Outcome - Report from EULAR 2026 Jun 15, 2026 00:06:01 Dr. Claudia Iannone delivers a vital expert perspective on the strategic management of comorbidities in patients with Rheumatoid Arthritis, featured at the EULAR 2026 Congress. This brief emphasizes the profound impact of cardiovascular, metabolic, and mental health conditions on RA progression, highlighting integrated care approaches and early screening protocols essential for optimizing long-ter

Novel Development in Treatment of Lupus - Report from EULAR 2026 Jun 15, 2026 00:04:59 Dr. Anca Dinu Askanase provides an essential expert overview of the latest breakthrough advancements and novel therapeutic developments in the treatment of Systemic Lupus Erythematosus (SLE), presented at the EULAR 2026 Congress. This recap highlights the evolving paradigm of targeted biologics, innovative small molecules, and combination strategies designed to achieve deeper clinical remission, m

Impact of Sonelokimab on Clinical and Imaging Outcomes in Axial Spondyloarthritis: Results of a Phase 2 Study - Report from EULAR 2026 Jun 15, 2026 00:04:15 Professor Xenofon Baraliakos, President of EULAR, presents pivotal data from a Phase 2 study evaluating the impact of sonelokimab, an IL-17A/F-inhibiting Nanobody, on clinical outcomes in axial spondyloarthritis. Highlighted at the EULAR 2026 Congress, this breakthrough recap explores how the integration of advanced 18F-NaF PET imaging and MRI provides unprecedented visualization of reduced bone i

From Diagnosis to Family Building: Navigating Fertility in RMDs - Report from EULAR 2026 Jun 15, 2026 00:09:18 Dr. Laura Andreoli and Dr. Karen Schreiber share essential insights from EULAR 2026 on managing fertility and family planning in patients with rheumatic and musculoskeletal diseases (RMDs). This recap explores clinical strategies from early diagnosis to pregnancy, focusing on safe medication management, patient counseling, and the multidisciplinary support needed to ensure positive maternal and fe

Novel Treatment Horizons in Lupus: Key Updates from EULAR 2026 Jun 15, 2026 00:02:50 Dr. Victoria Werth provides a concise update on the rapidly evolving therapeutic landscape for lupus, highlighting breakthrough data from EULAR 2026. This recap focuses on novel, targeted therapies designed to address unmet needs in both systemic (SLE) and cutaneous lupus (CLE), exploring how these precision strategies are successfully reshaping disease modification.Video: https://medicaldigest.or

Highlights of EULAR 2026 Jun 15, 2026 00:04:42 Professor Xenofon Baraliakos, President of EULAR, delivers an authoritative executive summary of the definitive highlights from the EULAR 2026 Congress in London. Reflecting on a record-breaking year of scientific submissions, this overview captures the most impactful advancements spanning basic translational research, groundbreaking clinical trials in rheumatology, and newly updated management gu

Chest HRCT in Detecting, Staging and Follow Up of SARD-ILD - Report from EULAR 2026 Jun 15, 2026 00:04:49 Dr. Muriel Elhai provides an essential expert overview of the critical role of chest high-resolution computed tomography (HRCT) in systemic autoimmune rheumatic disease-associated interstitial lung disease (SARD-ILD), presented at the EULAR 2026 Congress. This recap highlights the latest advancements in early HRCT screening protocols, radiographic staging techniques, and optimal monitoring strateg

Clinical Manifestations and Disease Course in Systemic Sclerosis - Report from EULAR 2026 Jun 15, 2026 00:13:37 Dr. Cristiana Sieiro Santos delivers a vital expert analysis on the heterogeneous clinical manifestations and unpredictable disease course of Systemic Sclerosis, featured at the EULAR 2026 Congress. This brief highlights the crucial updates in early risk stratification, the progression of organ-specific complications like interstitial lung disease (ILD), and how deep clinical phenotyping is drivin

Under the Surface: New Perspectives in Lupus with TLR7/8 Inhibition - Report from EULAR 2026 Jun 15, 2026 00:02:38 Dr. Victoria Werth provides an expert analysis of the EULAR 2026 session exploring the role of Toll-like receptor 7 and 8 (TLR7/8) inhibition in systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE). This recap looks beneath the surface at the underlying pathogenic mechanisms of the disease, highlighting the latest clinical data and new therapeutic perspectives on how targetin

Transitioning Young Patients with Autoinflammatory Diseases to Adult Care: Implications for Daily Clinical Management - Report from EULAR 2026 Jun 15, 2026 00:09:50 Dr. Marco Gattorno provides an essential overview of the EULAR 2026 session focused on the transition of young patients with autoinflammatory diseases from pediatric to adult rheumatology care. This recap highlights the practical and clinical implications for daily medical management, emphasizing the need for structured multidisciplinary protocols. The discussion explores how to maintain treatment

Advanced Management in Rheumatoid Arthritis: Critical Updates from EULAR 2026 Jun 15, 2026 00:09:33 Professor Ruxandra Ionescu delivers an expert overview of the EULAR 2026 session dedicated to the advanced management of Rheumatoid Arthritis. This comprehensive recap explores the latest clinical evidence, emerging therapeutic pathways, and refined treat-to-target protocols designed to address complex, difficult-to-treat cases. The discussion highlights practical strategies for optimizing long-te

Tired Is Not Just a State of Mind: Addressing Pathological Fatigue at EULAR 2026 Jun 15, 2026 00:09:42 Dr. Elena Elefante provides an expert look into the EULAR 2026 joint session "Tired is not just a state of mind," focusing on the clinical realities of pathological fatigue in patients with rheumatic and musculoskeletal diseases (RMDs). This overview dives into how chronic fatigue is increasingly recognized as a complex biological symptom rather than a purely psychological state. The rec

Assessment of Disease Activity in Psoriatic Arthritis - Report from EULAR 2026 Jun 15, 2026 00:04:59 Dr. Michael Zauner provides a comprehensive expert overview of the latest advancements in assessing disease activity in Psoriatic Arthritis, presented at the EULAR 2026 Congress. This recap explores the evolving role of multi-domain assessment tools, the integration of patient-reported outcomes, and how more precise tracking measures are shaping modern treat-to-target strategies to improve long-te

The Benefits of Glucagon/GLP-1 Receptor Dual Agonism: Insights from the SYNCHRONIZE™ Phase 3 Studies of Survodutide Jun 14, 2026 00:12:27 Dr. Carel le Roux delivers an expert overview of the highly anticipated findings from the SYNCHRONIZE™ Phase 3 clinical studies, presented at the ADA Scientific Sessions. The discussion focuses on the clinical benefits of glucagon/GLP-1 receptor dual agonism, showcasing new data on survodutide. This recap highlights how targeting both pathways offers a powerful approach to weight management and me

Lymphoma Highlights and Key Takeaways from the 2026 ASCO Annual Meeting Jun 10, 2026 00:11:54 Dr. Joshua Brody provides an expert overview of the most impactful clinical updates and essential takeaways from the 2026 ASCO Annual Meeting, focusing on groundbreaking advancements in lymphoma care. The recap explores the latest data on bispecific antibodies, including remarkable complete remission rates in Mantle Cell Lymphoma, crucial safety updates for outpatient administration, and the rapid

Immunotherapy in Early-Stage Breast Cancer - Report from ESMO BC 2026 Jun 2, 2026 00:12:01 Professor Giampaolo Bianchini discusses the evolving landscape of immunotherapy in early-stage breast cancer, focusing on predictive biomarkers, patient selection, and the integration of checkpoint inhibitors into neoadjuvant and adjuvant treatment settings to improve long-term outcomes.Video: https://medicaldigest.org/scientific-contents/interview:immunotherapy-early-stage-breast-cancer-report-es

The CAPItello-291 Trial: Final Overall Survival Results of Capivasertib and Fulvestrant in HR+/HER2− Advanced Breast Cancer - Report from ESMO BC 2026 Jun 2, 2026 00:25:29 Professor Hope S. Rugo discusses the final overall survival results from the Phase 3 CAPItello-291 trial, evaluating the efficacy, long-term disease control, and safety of combining the AKT inhibitor capivasertib with fulvestrant for patients with AI-resistant, HR+/HER2− advanced breast cancer.Video: https://medicaldigest.org/scientific-contents/interview:capitello-291-trial-final-overall-survival

Highlights and key takeaways from the 2026 EPA Congress May 15, 2026 00:09:44 Professor Meryam Schouler-Ocak provides an expert overview of the most impactful discussions, clinical updates, and essential takeaways from the 2026 EPA Congress, exploring the latest advancements and future directions in psychiatric research and practice.Video: https://medicaldigest.org/scientific-contents/interview:highlights-and-key-takeaways-2026-epa-congress

Efficacy and Safety of Sotatercept in PH-HFpEF: Results From the Phase 2 CADENCE Trial - report from ACC 2026 Apr 22, 2026 00:04:25 Professor Mardi Gomberg-Maitland presents the results from the Phase 2 CADENCE trial, investigating the efficacy and safety of Sotatercept in patients with combined post- and pre-capillary pulmonary hypertension associated with heart failure with preserved ejection fraction (HFpEF).Video: https://medicaldigest.org/scientific-contents/interview:efficacy-and-safety-sotatercept-ph-hfpef-results-phase

Therapeutic Novelties in the New ACC 2026 Acute Pulmonary Embolism Guideline Apr 22, 2026 00:07:54 Professor Geoffrey D. Barnes examines the therapeutic innovations introduced in the new ACC 2026 Acute Pulmonary Embolism Guideline, focusing on updated treatment protocols and novel anticoagulation strategies presented at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:therapeutic-novelties-new-acc-2026-acute-pulmonary-embolism-guideline

Human Challenge Models: A New Gold Standard? - Report from WVCDC 2026 Apr 20, 2026 00:11:06 Dr. Stephen Thomas examines the evolving role of human challenge models in vaccine development, debating whether they represent a new gold standard for establishing efficacy and safety at the World Vaccine Congress Washington 2026.Video: https://medicaldigest.org/scientific-contents/interview:human-challenge-models-new-gold-standard

The INSIS Metacohort Vaccine Safety Study: A Paradigm for Clinical and Immune AEFI Profiling - Report from WVCDC 2026 Apr 20, 2026 00:08:01 Professor Asimenia Angelidou discusses the INSIS Metacohort Vaccine Safety Study, establishing a new paradigm for profiling clinical and immune adverse events following immunization (AEFI) at the World Vaccine Congress Washington 2026.Video: https://medicaldigest.org/scientific-contents/interview:insis-metacohort-vaccine-safety-study-paradigm-clinical-and-immune-aefi-profiling

Building a Future of Vaccine Trust Through Transparency and Innovation - Report from WVCDC 2026 Apr 17, 2026 00:04:00 Dr. Yurong Fei-Bloom explores the essential strategies for fostering public confidence in immunization by prioritizing transparency and leveraging technological advancements at the World Vaccine Congress Washington 2026.Video: https://medicaldigest.org/scientific-contents/interview:building-future-vaccine-trust-through-transparency-and-innovation

Prove it's safe: Is this the new vaccine policy "norm?" - Report from WVCDC 2026 Apr 17, 2026 00:03:05 Dr. Richard Hughes IV examines the shifting landscape of immunization mandates and public health legislation, questioning whether the heightened demand for safety proof is becoming the new standard for vaccine policy at the World Vaccine Congress Washington 2026.Video: https://medicaldigest.org/scientific-contents/interview:prove-its-safe-new-vaccine-policy-norm

Combining Respiratory Vaccines - Balancing Efficacy, Durability and Immunization Schedules - Report from WVCDC 2026 Apr 17, 2026 00:06:32 Dr. Bill Hausdorff explores the complex dynamics of combining respiratory vaccines, focusing on how to optimize clinical efficacy and long-term durability while streamlining complex immunization schedules at the World Vaccine Congress Washington 2026.Video: https://medicaldigest.org/scientific-contents/interview:combining-respiratory-vaccines-balancing-efficacy-durability-and-immunization-schedule

Discontinuation of β-blocker Therapy in Stabilized Patients After Acute Myocardial Infarction - report from ACC 2026 Apr 16, 2026 00:04:02 Professor Joo-Yong Hahn presents critical insights on the discontinuation of beta-blocker therapy in stabilized patients following an acute myocardial infarction, discussing the clinical implications and trial findings at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:discontinuation-b-blocker-therapy-stabilized-patients-after-acute-myocardial-infarctio

Meet the Experts: 2025 High Blood Pressure Guideline - report from ACC 2026 Apr 16, 2026 00:03:01 Professor Daniel Jones joins a panel of distinguished specialists to provide expert commentary on the 2025 High Blood Pressure Guideline, focusing on evidence-based strategies for clinical implementation at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:2025-high-blood-pressure-guideline

2026 Acute Pulmonary Embolism Guideline Apr 16, 2026 00:06:34 Professor Gregory Piazza provides an expert overview of the newly released 2026 Acute Pulmonary Embolism Guideline, focusing on critical updates in diagnosis and management at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:acute-pulmonary-embolism-guideline-2026

Meet the Experts: 2025 High Blood Pressure Guideline - report from ACC 2026 Apr 16, 2026 00:07:25 Professor Keith C. Ferdinand joins a panel of experts to discuss the practical implementation and clinical implications of the 2025 High Blood Pressure Guideline at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:meet-experts-2025-high-blood-pressure-guideline

Kardinal: A Phase 2 Study of Tonlamarsen For the Treatment of Uncontrolled Hypertension - report from ACC 2026 Apr 16, 2026 00:08:56 Dr. Luke Laffin presents the results of the Kardinal Phase 2 study, investigating the efficacy of Tonlamarsen as a novel treatment option for patients with uncontrolled hypertension at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:kardinal-phase-2-study-tonlamarsen-treatment-uncontrolled-hypertension

Pulmonary Embolism in 2026: A Case-Based Journey From Diagnosis to Recovery - report from ACC 2026 Apr 16, 2026 00:13:34 Prof. Stanislav Henkin and Prof. Daniella Kadian-Dodov lead a comprehensive, case-based exploration of pulmonary embolism management in 2026, tracking the patient journey from initial diagnosis through to long-term recovery strategies at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:pulmonary-embolism-2026-case-based-journey-diagnosis-recovery

Mavacamten in Symptomatic Adolescent Patients With Obstructive HCM: Results From the Phase 3 Scout-HCM Trial - report from ACC 2026 Apr 16, 2026 00:02:52 Professor Joseph William Rossano presents the highly anticipated results from the Phase 3 Scout-HCM trial, evaluating the efficacy and safety of Mavacamten in symptomatic adolescent patients living with obstructive hypertrophic cardiomyopathy at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:mavacamten-symptomatic-adolescent-patients-obstructive-hcm-res

Saving Women's Hearts - report from ACC 2026 Apr 15, 2026 00:03:29 Professor Roxana Mehran addresses the critical need for gender-specific approaches in cardiovascular care, discussing strategies and clinical advancements aimed at saving women's hearts at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:saving-womens-hearts

Highlights of the 2026 ACC/AHA Dyslipidemia Guideline Apr 15, 2026 00:08:31 Professor Carol F. Kirkpatrick highlights the most critical updates and clinical recommendations from the 2026 ACC/AHA Dyslipidemia Guideline, focusing on new management targets and therapeutic strategies for lipid disorders at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:highlights-2026-accaha-dyslipidemia-guideline

An Update on Cardiac Prevention Medications: Hypertension and Incretin in Focus - report from ACC 2026 Apr 15, 2026 00:09:55 Professor Peter P. Toth provides a comprehensive update on the latest pharmacological strategies in cardiac prevention, specifically focusing on the evolving roles of hypertension management and incretin-based therapies at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:update-cardiac-prevention-medications-hypertension-and-incretin-focus

Effects of Tirzepatide vs. Dulaglutide on Cardiorenal Outcomes: SURPASS-CVOT Analysis - report from ACC 2026 Apr 15, 2026 00:08:08 Professor Steven E. Nissen presents a critical analysis of the SURPASS-CVOT data, comparing the effects of Tirzepatide and Dulaglutide on expanded cardiorenal outcomes in patients at high cardiovascular risk at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:effects-tirzepatide-vs-dulaglutide-cardiorenal-outcomes-surpass-cvot-analysis

Next-Generation Lipid Treatment Options - report from ACC 2026 Apr 15, 2026 00:06:13 Professor Robert S. Rosenson explores the evolving landscape of lipid management, detailing next-generation treatment options and their potential to transform cardiovascular risk reduction at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:next-generation-lipid-treatment-options

Fine tuning prostate cancer diagnostics - report from EAU 2026 Apr 15, 2026 00:05:20 Professor Armando Stabile discusses the latest advancements and precision methods in fine tuning prostate cancer diagnostics at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:fine-tuning-prostate-cancer-diagnostics

Prehospital Heparin Administration in Patients With STEMI Undergoing Primary PCI - report from ACC 2026 Apr 10, 2026 00:07:59 Prof. Misa Fister and Prof. Tomaz Goslar evaluate the clinical impact and safety of prehospital heparin administration for patients with STEMI undergoing primary PCI, sharing key findings at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:prehospital-heparin-administration-patients-stemi-undergoing-primary-pci

Interventional Cardiology Highlights of ACC.26 Apr 10, 2026 00:10:36 Professor Roxana Mehran provides an expert review of the most impactful interventional cardiology developments from the ACC 2026 Annual Congress, focusing on new stent technologies, structural heart interventions, and complex PCI outcomes.Video: https://medicaldigest.org/scientific-contents/interview:interventional-cardiology-highlights-acc26

Efficacy and Safety of Enlicitide Decanoate: Results from the Phase 3 CORALreef AddOn Trial - report from ACC 2026 Apr 10, 2026 00:08:10 Professor Alberico L. Catapano presents findings from the Phase 3 CORALreef AddOn trial, evaluating the oral PCSK9 inhibitor enlicitide decanoate versus bempedoic acid and ezetimibe in statin-treated patients with hypercholesterolemia.Video: https://medicaldigest.org/scientific-contents/interview:efficacy-and-safety-enlicitide-decanoate-results-phase-3-coralreef-addon-trial

Highlights of ACC.26 Apr 10, 2026 00:05:57 Professor Christopher Kramer shares the most significant breakthroughs, late-breaking clinical trials, and key takeaways from the ACC 2026 Annual Congress, summarizing the future of cardiovascular care.Video: https://medicaldigest.org/scientific-contents/interview:highlights-acc26

2026 Acute Pulmonary Embolism Guideline Apr 10, 2026 00:10:57 Professor Mark A. Creager provides an in-depth overview of the newly released 2026 Acute Pulmonary Embolism Guideline, highlighting key updates in clinical management and patient outcomes at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:2026-acute-pulmonary-embolism-guideline

Cutting-edge strategies in bladder cancer: Trials, techniques, and predictive tools - report from EAU 2026 Apr 7, 2026 00:09:53 Professor Richard P. Meijer explores the frontier of bladder cancer management, focusing on innovative clinical trials, advanced surgical techniques, and the implementation of predictive tools to improve patient outcomes at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:cutting-edge-strategies-bladder-cancer

MIBC - There is a gender bias in bladder cancer diagnosis and treatment - Women experience delays, misdiagnosis, worse outcomes - report from EAU 2026 Apr 7, 2026 00:05:30 Professor Niyati Lobo addresses the critical issue of gender bias in bladder cancer, highlighting how diagnostic delays and misdiagnoses lead to significantly worse clinical outcomes for women with MIBC at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:mibc-there-gender-bias-bladder-cancer-diagnosis-and-treatment-women-experience-delays-misdiagnosis-wor

Guidelines Controversies - Paeds and MIBC - report from EAU 2026 Apr 7, 2026 00:08:10 Professor Antoine G. van der Heijden explores the most debated topics within the EAU Guidelines, focusing on the latest controversies in pediatric urology and the management of Muscle-Invasive Bladder Cancer (MIBC) at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:guidelines-controversies-paeds-and-mibc

Adaptive recurrence risk predictions to optimise prostate cancer follow-up: Results of model validation and clinical impact - report from EAU 2026 Apr 7, 2026 00:04:28 Joran Schoorlemmer presents the results of model validation and the clinical impact of adaptive recurrence risk predictions, focusing on how these tools can optimise follow-up strategies for prostate cancer at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:adaptive-recurrence-risk-predictions-optimise-prostate-cancer-follow-results-model-validation-and-

The role of urine biomarkers in detection of bladder cancer - report from EAU 2026 Apr 7, 2026 00:06:36 Professor Yair Lotan examines the clinical utility and future potential of urine biomarkers, focusing on how they are transforming the early detection and surveillance of bladder cancer at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:role-urine-biomarkers-detection-bladder-cancer

Urology trials in bladder and prostate cancer - report from EAU 2026 Apr 7, 2026 00:06:22 Professor Ashkan Mortezavi provides a comprehensive overview of the most significant recent and ongoing clinical trials in bladder and prostate cancer, highlighting their impact on future treatment standards at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:urology-trials-bladder-and-prostate-cancer

Cutting-edge strategies in bladder cancer: Trials, techniques, and predictive tools - report from EAU 2026 Apr 7, 2026 00:05:28 Professor Nikhil Vasdev explores the latest advancements in bladder cancer management, focusing on clinical trials, innovative surgical techniques, and the use of predictive tools at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:cutting-edge-strategies-bladder-cancer-trials-techniques-and-predictive-tools

Redefining EMBARK-like Patients in the PSMA Era: Impact of PSMA-PET Restaging on Disease Classification and Management - report from EAU 2026 Apr 7, 2026 00:03:01 Professor Alessandro Viti discusses the impact of PSMA-PET restaging on disease classification and management, redefining "EMBARK-like" patients in the modern PSMA era at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:redefining-embark-patients-psma-era-impact-psma-pet-restaging-disease-classification-and-management

Progression-free survival following primary staging with [¹⁸F]PSMA-1007 PET/ceCT versus Na[¹⁸F]F-PET/ceCT in prostate cancer: Results from the PRISMA PET randomized controlled trial Apr 7, 2026 00:05:26 Karen Middelbo Buch-Olsen and Mads Hvid Poulsen present the highly anticipated results from the PRISMA PET randomized controlled trial, comparing progression-free survival in prostate cancer staging between [¹⁸F]PSMA-1007 PET/ceCT and Na[¹⁸F]F-PET/ceCT at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:progression-free-survival-following-primary-staging-

2026 EAU Guidelines update and controversies – Urolithiasis, female and male LUTS and infections: What has changed? Apr 7, 2026 00:05:00 Professor Arjun Konath Nambiar provides a critical update on the 2026 EAU Guidelines, exploring the latest changes and ongoing controversies in urolithiasis, male and female LUTS, and urological infections at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:2026-eau-guidelines-update-and-controversies-urolithiasis-female-and-male-luts-and-infections-what-

Infections: Prophylactic antibiotics in renal cancer surgery - Safeguarding patients from postoperative infection - report from EAU 2026 Apr 7, 2026 00:03:44 Professor Florian M. E. Wagenlehner discusses the critical role of prophylactic antibiotics in renal cancer surgery and effective strategies for safeguarding patients from postoperative infections at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:infections-prophylactic-antibiotics-renal-cancer-surgery-safeguarding-patients-postoperative-infection

Antibiotics & renal health: Striking the perfect balance between benefit and risk - report from EAU 2026 Apr 7, 2026 00:05:30 Professor Merel M.C. Lambregts discusses the delicate clinical challenge of antibiotics and renal health, exploring how to strike the perfect balance between therapeutic benefit and potential risk at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:antibiotics-renal-health-striking-perfect-balance-between-benefit-and-risk

Navigating the future of urologic care - report from EAU 2026 Apr 7, 2026 00:06:06 Professor Andreas Røder discusses the evolving landscape and strategic shifts navigating the future of urologic care at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:navigating-future-urologic-care

From MRI to Post-treatment care: prostate cancer screening - report from EAU 2026 Apr 7, 2026 00:04:31 Professor Hendrik Van Poppel discusses the complete pathway of prostate cancer screening, from the initial role of MRI to the nuances of post-treatment care at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:mri-post-treatment-care-prostate-cancer-screening

Prostate cancer: PARPIs finally explained - report from EAU 2026 Apr 7, 2026 00:10:16 Professor Alexander W. Wyatt breaks down the complexities of PARP inhibitors (PARPIs), providing a clear and comprehensive explanation of their role in treating prostate cancer at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:prostate-cancer-parpis-finally-explained

Retroperitoneal lymph dissection considerations in testicular cancer - report from EAU 2026 Apr 7, 2026 00:06:56 Professor Anna Thor discusses the critical clinical considerations and surgical nuances of retroperitoneal lymph node dissection in the management of testicular cancer at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:retroperitoneal-lymph-dissection-considerations-testicular-cancer

Episodes

Recommended